| Literature DB >> 26582947 |
Yafei Huang1, Andrew Getahun2, Ryan A Heiser3, Thiago O Detanico3, Katja Aviszus3, Greg A Kirchenbaum2, Tamara L Casper3, Chunjian Huang3, M Kemal Aydintug3, Simon R Carding4, Koichi Ikuta5, Hua Huang3, Lawrence J Wysocki6, John C Cambier6, Rebecca L O'Brien6, Willi K Born7.
Abstract
We previously reported that selective ablation of certain γδ T cell subsets, rather than removal of all γδ T cells, strongly affects serum Ab levels in nonimmunized mice. This type of manipulation also changed T cells, including residual γδ T cells, revealing some interdependence of γδ T cell populations. For example, in mice lacking Vγ4(+) and Vγ6(+) γδ T cells (B6.TCR-Vγ4(-/-)/6(-/-)), we observed expanded Vγ1(+) cells, which changed in composition and activation and produced more IL-4 upon stimulation in vitro, increased IL-4 production by αβ T cells as well as spontaneous germinal center formation in the spleen, and elevated serum Ig and autoantibodies. We therefore examined B cell populations in this and other γδ-deficient mouse strains. Whereas immature bone marrow B cells remained largely unchanged, peripheral B cells underwent several changes. Specifically, transitional and mature B cells in the spleen of B6.TCR-Vγ4(-/-)/6(-/-) mice and other peripheral B cell populations were diminished, most of all splenic marginal zone (MZ) B cells. However, relative frequencies and absolute numbers of Ab-producing cells, as well as serum levels of Abs, IL-4, and BAFF, were increased. Cell transfers confirmed that these changes are directly dependent on the altered γδ T cells in this strain and on their enhanced potential of producing IL-4. Further evidence suggests the possibility of direct interactions between γδ T cells and B cells in the splenic MZ. Taken together, these data demonstrate the capability of γδ T cells of modulating size and productivity of preimmune peripheral B cell populations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26582947 PMCID: PMC4684964 DOI: 10.4049/jimmunol.1501064
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422